Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (18)

1

High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma

enthalten in: British journal of haematology | 2022

von Aydin, M. | Tang, M. | Wondergem, M. | +7

2

Increased mortality risk in multiple-myeloma patients with subsequent malignancies : a population-based study in the Netherlands

enthalten in: Blood cancer journal | 2022

von Brink, M. | Minnema, M. | Visser, O. | +12

3

Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study

enthalten in: Haematologica | 2021

von Hulin, C. | Offner, F. | Moreau, P. | +20

4

Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma

enthalten in: Haematologica | 2021

von Kinder, M. | Bahlis, N. | Malavasi, F. | +7

5

First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands : a population-based study, 1989-2018

enthalten in: Blood cancer journal | 2021

von Brink, M. | Visser, O. | Zweegman, S. | +4

6

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial

enthalten in: Haematologica | 2020

von Zweegman, S. | Stege, C. | Haukas, E. | +23

7

Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities

enthalten in: Leukemia | 2020

von Stege, C. | van der Holt, B. | Dinmohamed, A. | +6

CommentOn: Leukemia. 2020 Jan;34(1):224-233. - PMID 31427722

8

Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

enthalten in: Haematologica | 2020

von Frerichs, K. | Bosman, P. | van Velzen, J. | +8

9

Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma

enthalten in: Haematologica | 2020

von Holthof, L. | van der Horst, H. | van Hal-van Veen, S. | +11

10

CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

enthalten in: Haematologica | 2019

von Naik, J. | Themeli, M. | de Jong-Korlaar, R. | +11